(PharmaNewsWire.Com, May 22, 2021 ) The trocars market is expected to reach USD 762.3 million by 2023 from USD 502.8 million in 2017, at a CAGR of 7.2% during the forecast period. The major factors driving the growth of this market are the increasing prevalence of cancer and hernia and growing preference for minimally invasive surgery.
Disposable trocars are expected to account for the largest market share in 2018
By product, the trocars market is classified into disposable trocars, reposable trocars, reusable trocars, and accessories. The disposable trocars segment is estimated to command the largest market share in 2018. Their cost-effectiveness, user-friendliness, and safety have resulted in their greater adoption, as compared to reusable trocars.
Bladeless trocars segment is expected to account for the largest share of the trocars market in 2018
By tip, trocars market segment segmented into bladeless trocars, optical trocars, blunt trocars, and bladed trocars. In 2018, the disposable trocars segment is estimated to account for largest market share. This is mainly due to the ease of use of bladeless tip trocars, which minimize trauma to the abdominal wall and vessels. Moreover, the ergonomic design of these trocars offers high stability.
The general surgery segment is estimated to grow at the highest CAGR during the forecast period
The application segment is further segmented into general surgery, gynecological surgery, pediatric surgery, urological surgery, and other surgeries. The general surgery segment is estimated to register the highest growth during the forecast period. The key factors driven by the growth of this segment is the rising prevalence of obesity, hernia, and appendicitis.
North America is estimated to command the largest share of the market in 2018
Based on region, the trocars market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America is expected to account for the largest share of the global trocars market. The large share can primarily be attributed to the increasing prevalence & incidence of cancer, hernia, and appendicitis. The strong presence of major market players in this region ensures easy access to trocars.
Key players in the trocars market include Medtronic (Ireland), Ethicon (US), B. Braun (Germany), Applied Medical (US), Cooper Companies (US), Teleflex (US), ConMed (US), LaproSurge (UK), Purple Surgical (UK), and GENICON (US).
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
